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186 The Journal of Thoracic and Cardbjective: The aging of the population and a longer life expectancy have led to an
ncreased number of elderly patients with esophageal cancer being referred for
urgical treatment. The aim of this study was to assess the effects of age on the
utcome of surgery for esophageal cancer at a single institution.
ethods: Perioperative outcome and long-term survival of patients at least 70 years
ld undergoing esophagectomy between 1992 and 2005 for cancer of the esophagus
r esophagogastric junction were compared with findings in younger patients.
atients who underwent an abdominal procedure only were excluded from the
nalysis.
esults: The analysis considered 580 patients younger than 70 years and 159 at least
0 years old. Clinical presentation in the two groups was similar, as were postop-
rative morbidity and mortality, despite significant differences in perioperative risk
actors. Irrespective of age, overall survival was 34% at 5 years for all patients and
7% for patients with R0 resection.
onclusions: Increased experience and refinements in perioperative care explain
he better results of esophagectomy in elderly patients in recent years. Short- and
ong-term outcomes after esophagectomy for carcinoma in patients older than 70
ears are comparable with those of their younger counterparts. Advanced
ge per se thus should not be considered a contraindication to esophageal
esection.
he aging of the population and a longer life expectancy have led to more
elderly patients with esophageal carcinoma being referred for surgical treat-
ment. Controversies exist concerning the effect of advanced age on the
utcome of esophagectomy. There is an apparent contradiction between reports in
hich the individual risk of mortality after esophagectomy is strongly related to the
atient’s age and performance status, with worse long-term survival among elderly
atients,1-3 and studies confirming improvements in the results of esophagectomy
n patients 70 years old and older (mostly as a result of advances in perioperative
are), with morbidity and mortality rates comparable to those in their younger
ounterparts.4-7 The aim of this study was to evaluate the effects of advanced age on
he surgical outcome and long-term survival of patients undergoing esophagectomy
or esophageal cancer at a single high-volume center.
atients and Methods
e evaluated all patients with cancer of the esophagus or esophagogastric junction (Siewert
ype I-II) seen at our department between January 1992 and June 2005. Preoperative workup
ncluded physical examination, standard laboratory tests, lung function tests, and anesthesio-
iovascular Surgery ● May 2007
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G
TSogic assessment. In selected cases, noninvasive cardiac evaluation
echocardiogram or dynamic tests to estimate ventricular function)
ere also performed. The American Society of Anesthesiologists
lassification was used to assess the operative risk. Barium swal-
ow study and upper gastrointestinal endoscopy were performed to
ssess the tumor’s features; flexible bronchoscopy and otolaryn-
ologic evaluation were added for tumors of the cervical, upper,
nd middle esophagus. Computed tomographic scans of the chest
nd abdomen (and neck in selected cases) were obtained in all
ases to rule out any metastatic disease. Endoscopic ultrasonogra-
hy was used from 2000 onward to provide additional information
n tumor depth and lymph node status.
Complete tumor resection was defined as R0, and incomplete
esection with microscopic or macroscopic residual disease was
efined as R1 or R2, respectively. Perioperative mortality was
lassed as in-hospital mortality (all deaths occurring at the hospi-
al) and 30-day mortality (all deaths occurring within 30 days of
urgery). Postoperative morbidity included any minor or major
edical or surgical complications. Anastomotic leaks were re-
orded, both symptomatic leaks and small asymptomatic leaks
etected on radiologic examination.
urgery
sophagectomy was performed with an Ivor–Lewis procedure,
hrough a laparotomy and right thoracotomy, for mid to lower
sophageal and esophagogastric junction tumors. A 3-stage Mc-
eown procedure, with an additional left cervical incision, was
eserved for tumors in the upper third of the esophagus. At least 6
o 8 cm of healthy esophagus was resected above the proximal
dge of the tumor to avoid neoplastic involvement of the resection
argins. In patients undergoing resection with a curative intent, en
loc lymph node dissection was performed, including the per-
esophageal, infracarinal, posterior mediastinal, and paracardial
ymph nodes, as well as those located along the lesser gastric
urvature, the origin of the left gastric artery, the celiac trunk, the
ommon hepatic artery, and the splenic artery (with the cervical,
ecurrent laryngeal chains, and paratracheal nodes also resected for
ancers of the cervical and upper thoracic esophagus). The alimen-
ary tract was reconstructed immediately, preferably with the gas-
ric pull-up technique; if the stomach was unavailable, either a
ejunal loop or the left colon was used. Anastomoses were per-
ormed with a circular stapling device in the thoracic cavity and a
ouble layer of hand-sewn running suture in the neck. For patients
ith cancer of the cervical esophagus, a pharyngolaryngoesoph-
gectomy was performed.
Postoperative patient care included early extubation (preferably
n the operating room), aggressive respiratory care with frequent
ronchoscopic suctioning, pain control (epidural analgesia along
ith patient-controlled analgesia), vigorous respiratory therapy,
nd early mobilization and ambulation. Food intake was allowed,
rovided a Gastrografin swallow showed no evidence of leakage,
n postoperative days 7 and 10 for stapled and hand-sewn anas-
omoses, respectively.
Patients were followed up routinely by their surgeons 1, 3, 6,
nd 12 months after the operation and every 6 to 12 months
hereafter. t
The Journal of Thoracictatistical Analysis
ata are expressed as medians and interquartile ranges. Propor-
ions were compared with the 2 or Fisher exact test. Continuous
ariables were compared with the Mann–Whitney test. Survival
stimates were calculated by the Kaplan–Meier method, and sur-
ival comparisons were performed with the log–rank test. Cox
roportional hazard models were used to identify independent
redictors of survival.
esults
f the 1400 patients with esophageal or esophagogastric
unction cancer seen at our department between January
992 and June 2005, a total of 764 (54.6%) underwent
sophagectomy (Table 1). A significantly higher percentage
f patients younger than 70 years underwent surgical resec-
ion relative to those at least 70 years old (57.3% vs 46.5%,
 .0004). We excluded from further analysis 25 patients
ho underwent a transabdominal procedure only (n  14),
ree jejunal transplantation (n  1), myocutaneous flap
econstruction (n  5), or esophageal resection without
econstruction (n  5). The remaining 739 patients formed
he study population: 580 (78.5%) patients were younger
han 70 years (group A) and 159 (21.5%) were at least 70
ears old (group B). In the latter, elderly group, 107 (67.3%)
atients were between 70 and 74 years old, 43 (27%) were
ged 75 to 79 years, and 9 (5.7%) were in their 80s.
linicopathologic Characteristics
he demographic information and clinical characteristics of
he patients in the two groups are summarized in Table 2. As
xpected, preoperative cardiovascular and respiratory risk
actors were significantly more prevalent in group B. Tumor
haracteristics at presentation in the two groups are shown
n Table 3. Tumor location and histologic type differed
etween the two groups, with a higher proportion of ade-
ocarcinoma and a lower tumor location among the older
atients. Table 4 summarizes the treatment details and
athologic findings at surgery. There were no significant
ifferences in tumor stage or degree of differentiation be-
ABLE 1. Treatment strategies by age group
Surgical
resection
No surgical
resection*
ll patients (n  1400) 764 (54.6%) 636 (45.4%)
atients 70 y (n  1045) 599 (57.3%) 446 (42.7%)
atients 70 y (n  355) 165 (46.5%) 190 (53.5%)
value† .0004
ata are expressed as numbers of patients with percentages in parentheses.
Including bypass operation, chemotherapy, radiotherapy, endoscopic di-
ation, endoscopic prosthesis placement, endoscopic laser therapy, feed-
ng jejunostomy or gastrostomy, or any combination of these. †Surgical
esection versus no surgical resection.ween groups A and B. Overall, 90% of the patients were
and Cardiovascular Surgery ● Volume 133, Number 5 1187
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G
TSonsidered to have curative resection (R0): 514 (88.6%) of
80 in group A and 147 (92.5%) of 159 in group B (P 
191). The effects of neoadjuvant treatment in groups A and
 are shown in Table 5.
orbidity and Mortality
verall, the in-hospital mortality rate 2.6% (19/739): 2.7%
16/580) among patients younger than 70 years and 1.9%
3/159) among the older patients (P  .778). The overall
0-day mortality was 1.9% (14/739): 1.9% (11/580) in
roup A and 1.9% (3/159) in group B (P  .999). The
ABLE 2. Demographic and clinical characteristics
ex (male/female)
ge (y, median with interquartile range)
istory of cardiac disease (No.)
Yes
No
istory of respiratory disease (No.)
Yes
No
istory of vascular disease (No.)
Yes
No
merican Society of Anesthesiologists classification (No.)
1-2
3-4
Data unavailable
eight loss (10% body weight, No.)
ABLE 3. Tumor characteristics
Patient
Histopathologic type
Squamous cell carcinoma 3
Adenocarcinoma 1
Others
History of Barrett esophagus†
Tumor site
Cervical
Upper thoracic 1
Mid thoracic 1
Lower thoracic 1
Esophagogastric junction (Siewert type I-II) 1
Clinical TNM stage
Stage 0
Stage I
Stage II 2
Stage III 2
Stage IV
Data unavailable
ata are expressed as numbers of patients with percentages in pare
denocarcinoma. †Analysis limited to patients with adenocarcinoma only.
188 The Journal of Thoracic and Cardiovascular Surgery ● Maverall morbidity rate was 48.7% (360/739): 48.6% (282/
80) in group A and 49.1% (78/159) in group B (P .929).
etails of the postoperative complications in the two groups
re given in Table 6. The most common complications were
ulmonary and cardiovascular, and they were more preva-
ent among older patients.
urvival
he median survivals were 23.1 months (interquartile
ange 11.8-46.4 months) for patients younger than 70
ears and 17.9 months (interquartile range 9.2-44.4
nts <70 y (n  580) Patients >70 y (n  159) P value
472/108 124/35 .365
59.5 (53.4–64.6) 73.1 (71.6–76.6)
.0001
72 (12.4%) 47 (29.6%)
508 (87.6%) 112 (70.4%)
.003
87 (15%) 40 (25.2%)
493 (85%) 119 (74.8%)
.0006
33 (5.7%) 23 (14.5%)
547 (94.3%) 136 (85.5%)
.0001
436 (77%) 91 (58.7%)
130 (23%) 64 (41.3%)
14 4
121 (21.7%) 27 (17.4%) .265
y (n  580) Patients >70 y (n  159) P value
.0001*
4.1%) 77 (48.4%)
1.6%) 77 (48.4%)
.3%) 5 (3.2%)
7.3%) 23 (29.9%) .763
.001
.9%) 4 (2.5%)
9%) 24 (15.1%)
6.5%) 37 (23.3%)
9%) 23 (14.5%)
7.6%) 71 (44.6%)
.683
.7%) 5 (3.2%)
2.1%) 20 (12.7%)
5.6%) 71 (44.2%)
5.2%) 50 (31.9%)
.4%) 11 (7.0%)
2
ses. TNM, Tumor-node-metastasis. *Squamous cell carcinoma versusPaties <70
72 (6
83 (3
25 (4
50 (2
46 (7
10 (1
54 (2
10 (1
60 (2
10 (1
70 (1
63 (4
03 (3
31 (5
3
nthey 2007
ms
(
r
w
F
b
a
w
v
w
i
t
T
h
p
D
S
w
e
e
a
f
p
d
w
n
o
W
m
l
p
T
N
A
R
P
D
R
* ‡Data
T
S
S
S
S
S
D
p
p
Ruol et al General Thoracic Surgery
G
TSonths) for those older. Five-year survival for the whole
eries was 34%: 33.6% in group A and 35.4% in group B
 P  .257; Figure 1). When patients with R0 curative
esection were considered alone, the 5-year survivals
ere 37% for group A and 39% for group B (P  .279;
igure 2). There was no significant difference in survival
etween male and female patients, either overall or in the
ge subgroups, but the 5-year survival in the older age group
as higher for female patients than for male patients (48%
s 32%, difference not significant). When the older group
as assessed separately, there was no significant difference
ABLE 4. Surgical treatment and pathologic findings
eoadjuvant therapy
ccess
Laparotomy  thoracotomy (right)
Thoracotomy (right)  laparotomy  cervicotomy (left)
Laparotomy  cervicotomy (left)
econstruction
Stomach
Colon
Other
athologic TNM stage
Stage 0
Stage I
Stage II
Stage III
Stage IV
Data not available
egree of tumor differentiation‡
Well or moderately differentiated
Poorly differentiated
Data not available
esection
R0
R1-2
Transthoracic versus nontransthoracic access. †Stomach versus colon.
ABLE 5. Effect of neoadjuvant treatment
Patients <70 y (n  214) Patients >70 y (n  28)
Clinical stage*
Pathologic
stage Clinical stage†
Pathologic
stage
tage 0 0 49 (22.9%) 0 8 (28.6%)
tage I 4 (1.9%) 19 (8.9%) 0 3 (10.7%)
tage II 63 (29.7%) 72 (33.6%) 3 (11.1%) 10 (35.7%)
tage III 120 (56.6%) 52 (24.3%) 18 (66.7%) 5 (17.9%)
tage IV 25 (11.8%) 22 (10.3%) 6 (22.2%) 2 (7.1%)
ata are expressed as numbers of patients with percentages in
arentheses. *Data not available for 2 patients. †Data not available for 1datient.
The Journal of Thoracicn 5-year survival between patients 70 to 74 years old and
hose at least 75 years of age.
Details of univariate analysis of survival are shown in
able 7. Cox multivariate analysis identified tumor stage,
istologic type, and degree of differentiation as independent
redictors of long-term survival (Table 8).
iscussion
ome important observations emerge from this study. First,
ith current advances in surgical management and periop-
rative care, elective esophagectomy can be safe even in
lderly patients with medical risk factors if the tumor is
menable to surgical resection. Second, long-term survival
or elderly patients is comparable with that of younger
atients.
Worldwide increase in the elderly population in the last
ecades has made surgeons face the everyday dilemma of
hether to perform major surgery on an elderly patient. The
eed for digestive tract surgery for patients at least 70 years
ld is becoming a serious and crucial health problem in
estern countries. There have been advances in the multi-
odal management of many digestive tract cancers in the
ast 3 decades, but for many of them—esophageal cancer in
articular—surgery remains the mainstay of treatment. Un-
Patients <70 y
(n  580)
Patients >70 y
(n  159) P value
214 (36.9%) 28 (17.6%) .0001
.608*
373 (64.3%) 114 (71.7%)
128 (22.1%) 21 (13.2%)
79 (13.6%) 24 (15.1%)
.597†
528 (91%) 147 (92.4%)
41 (7.1%) 9 (5.7%)
11 (1.9%) 3 (1.9%)
.598
62 (10.7%) 13 (8.2%)
81 (14%) 25 (15.7%)
177 (30.6%) 41 (25.8%)
202 (35%) 62 (39%)
56 (9.7%) 18 (11.3%)
2 0
.831
421 (76.3%) 115 (75.2%)
131 (23.7%) 38 (24.8%)
3 1
.191
514 (88.6%) 147 (92.5%)
66 (11.4%) 12 (7.5%)
refer to squamous cell carcinoma and adenocarcinoma only.oubtedly, esophagectomy is a major surgical procedure,
and Cardiovascular Surgery ● Volume 133, Number 5 1189
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G
TSnd its high postoperative morbidity and mortality are well
ecognized. Nonetheless, improvements in perioperative
are and recent studies reporting much the same morbidity
nd mortality rates among elderly patients undergoing
sophageal resection as among their younger counterparts
ave prompted a reassessment of the true effect of age on
he outcome of esophagectomy for esophageal cancer.
The idea that older age itself contraindicates major sur-
ery such as esophagectomy seems to be a misconception.
f course, careful preoperative risk assessment is important
n selecting patients for esophagectomy. A significant num-
er of our elderly patients had preoperative cardiovascular
r pulmonary dysfunction and similarly had cardiopulmo-
ary complications in the postoperative period. Pulmonary
omplications were among the most frequent causes of
orbidity among both younger and older patients, which
ABLE 6. Morbidity and mortality
ortality
In hospital
At 30 d
omplications
Pulmonary (pneumonia, atelectasis, lung failure)
Cardiovascular (myocardial infarction, severe arrhythmia,
pulmonary edema, pulmonary embolism)
Other
Chylothorax
Laryngeal nerve palsy
Anastomotic leak or graft necrosis
Hemorrhage
Renal failure
Wound infection
eoperations
ata are expressed as numbers of patients with percentages in parenthe
igure 1. Kaplan–Meier survival curves (including postoperative
eaths) plotted for patients younger than 70 years versus patients
0 years old and older, all resections (2  1.286, P  .257). 7
190 The Journal of Thoracic and Cardiovascular Surgery ● Mamphasizes the importance of frequent bronchoscopic suc-
ioning and incentive spirometry before and after the oper-
tion, performed routinely by patients or preferably by a
espiratory therapist.
The mortality did not differ significantly between our
wo age groups, and there are several factors responsible for
his result. First is greater experience1,8 and refinement in
urgical technique: all esophagectomies were performed by
he same team of surgeons specializing in esophageal
urgery. Improved perioperative patient care has also
ontributed to reduce related morbidity (especially pul-
onary complications) and mortality. Most of all, post-
perative epidural analgesia for better pain control and
ess interference with pulmonary mechanics has helped,
long with incentive spirometry, to improve postopera-
ive lung activity.9
ents <70 y (n  580) Patients >70 y (n  159) P value
16 (2.7%) 3 (1.9%) .778
11 (1.9%) 3 (1.9%) .999
89 (15.3%) 27 (17%) .623
29 (5%) 15 (9.6%) .056
10 (1.7%) 0 .130
46 (7.9%) 12 (7.5%) .999
53 (10.2%) 12 (7.5%) .636
4 (0.7%) 3 (1.9%) .174
5 (0.9%) 0 .59
10 (1.7%) 1 (0.6%) .472
20 (3.4%) 4 (2.5%) .800
igure 2. Kaplan–Meier survival curves (including postoperative
eaths) plotted for patients younger than 70 years versus patientsPati0 years old and older, R0 resections only (2  1.169, P  .279).
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G
TSKeeping in mind the previously mentioned results, we
eed to remember that they were obtained in a selected
opulation of elderly patients. A significantly higher pro-
ortion of patients 70 years of age or older did not undergo
urgery than their younger counterparts. When we analyzed
he reasons for exclusion from surgery (data not shown), we
ound out that nearly 40% of elderly patients were excluded
or comorbidity-related reasons; this cause accounted for
ewer than 20% of exclusions of surgery among the younger
ubjects.
The reported 5-year survival after resection for esopha-
eal carcinoma is in the 15% to 20% range,10,11 a fact that
as raised concerns regarding the advisability of such an
xtensive procedure as esophagectomy in elderly pa-
ients.12,13 Palliative treatments have been advocated as the
ole treatment option for such patients, although it is well
nown that the median survival after palliation is only 4
onths. The overall 5-year survival in our series was more
han 34%. What is more, there was no significant differ-
nce between older and younger patients. As shown
reviously,2,7,14-15 if elderly patients can survive the
sophagectomy itself, then the 5-year survival is inde-
endent of age. When we analyzed the long-term results
f our at least 75-year-old patients, they fared just as well
s their younger counterparts, if not better.
Interestingly, we didn’t find any significant difference in
verall survival between male and female patients, and we
ABLE 7. Univariate analysis of survival
5-y survival (%) P value
ge (y) .26
70 33.6%
70 35.4%
ex .177
Male 33.3%
Female 36.6%
umor location .52
Cervical, upper thoracic, mid thoracic 32.2%
Lower thoracic, esophagogastric
junction (Siewert type I-II)
36%
istologic type .15
Squamous cell carcinoma 32.1%
Adenocarcinoma 38%
eoadjuvant therapy .38
Yes 36%
No 33%
athologic TNM stage .0001
Stage 0, I, or II 49.5%
Stage III or IV 15.3%
egree of tumor differentiation .004
Well or moderately differentiated 36.6%
Poorly differentiated 26.7%nterpreted the loss of prognostic effect of female sex as l
The Journal of Thoracicrobably the result of a higher percentage of esophageal
quamous cell carcinoma among female patients than
mong male patients. This study was not designed to assess
he relationship between sex, histologic type, and survival,
owever, and such will require further detailed analysis of
ur data.
Esophageal resection not only restores swallowing func-
ion, which means restoration of a decent quality of life, but
t also gives patients a chance of cure. In other words, it is
orthwhile. This study did not intend to assess the details of
ach single prognostic factor for survival among patients
ndergoing esophagectomy for esophageal cancer, but a
eview of the 739 esophagectomies included in this series,
erformed at our institution during the last 14 years, showed
hat older age did not affect long-term survival.
It is important to remember when discussing the results
f this study that they were achieved in a specialized center
or esophageal diseases. It is now widely recognized that
ertain high-risk surgical procedures have lower mortality
nd morbidity as well as better outcome when performed in
igh-volume centers.16,17 This is specifically true for esoph-
geal cancer surgery, with individual surgeon experience,
xpert team assistance, and access to better infrastructure
esources to manage critically ill patients all playing a
eterminant role.
In summary, increased surgical experience and refine-
ents in perioperative care can explain the improved
esults achieved with esophagectomy in elderly patients
n recent years. Short- and long-term outcomes after
sophagectomy for carcinoma in patients 70 years old or
lder are equivalent to those of their younger counter-
arts. Advanced age per se thus should not be considered
contraindication to esophageal resection. For selected
atients who are fit for surgery and have resectable
esions, esophagectomy is indicated and worthwhile, re-
ardless of age. A careful selection of candidates for
urgery is mandatory, however, to keep morbidity and
ortality to acceptable levels and achieve much the same
ABLE 8. Multivariate analysis of predictors of survival
2 P value
ge group (70 y) 2.41 .12
ex (male) 2.62 .11
umor location (upper site)* 0.7 .4
eoadjuvant therapy (none) 0.09 .76
istologic type (squamous) 7.89 .005
egree of tumor differentiation (poor) 3.92 .048
umor stage (p III-IV) 97 .0001
Upper sites include cervical, upper thoracic, and mid-thoracic tumor
ocations.ong-term survival for younger and older patients.
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